Home / Advanced Search

  • Title/Keywords

  • Author/Affliations

  • Journal

  • Article Type

  • Start Year

  • End Year

Update SearchingClear
  • Articles
  • Online
Search Results (23,797)
  • Open Access

    EDITORIAL

    Romanow, Romanow, wherefore art thou Romanow?

    Laurence H. Klotz

    Canadian Journal of Urology, Vol.9, No.6, pp. 1672-1673, 2002

    Abstract This article has no abstract. More >

  • Open Access

    EDITORIAL COMMENT

    Transperitoneal laparoscopic radical nephrectomy for bulky renal tumors - Page 1653

    Andrew C. Novick

    Canadian Journal of Urology, Vol.9, No.5, pp. 1660-1660, 2002

    Abstract This article has no abstract. More >

  • Open Access

    HOW I DO IT

    Transperitoneal laparoscopic radical nephrectomy for bulky renal tumors

    Stephen E. Pautler, McClellan M. Walther

    Canadian Journal of Urology, Vol.9, No.5, pp. 1653-1659, 2002

    Abstract Laparoscopic management of kidney cancer is becoming accepted as an alternative to open radical nephrectomy. Technical considerations have limited the application of laparoscopic radical nephrectomy to relatively small, clinically localized tumors. At the National Cancer Institute, we have broadened the indications to include bulky tumors. Herein, we describe the operation with attention to the technical caveats that have been gained with experience. More >

  • Open Access

    CASE REPORT

    Retroperitoneoscopic left nephrectomy in a horseshoe kidney with the use of the harmonic scalpel

    Steven P. Lapointe, Anne-Marie Houle, Diego Barrieras

    Canadian Journal of Urology, Vol.9, No.5, pp. 1651-1652, 2002

    Abstract Laparoscopy has greatly evolved over the years. More recently, retroperitoneoscopy has gained wide acceptance as the preferred approach for simple and complicated nephrectomies. We report on a 12 year-old girl who underwent a left nephrectomy on a horseshoe kidney through a retroperitoneoscopic approach using the harmonic scalpel for dissection and isthmus division. The operation was successful, recovery uneventful, and the patient was discharged 24 hrs post operatively, with excellent cosmesis. Retroperitoneoscopy can be considered if ablative surgery is contemplated in a horseshoe kidney, with adequate preoperative evaluation and solid retroperitoneoscopic surgical experience. The use the More >

  • Open Access

    CASE REPORT

    Management of urethral catheter knot in a neonate

    Eric Mayer, Murali K. Ankem, Victor H. Hartanto, Joseph G. Barone

    Canadian Journal of Urology, Vol.9, No.5, pp. 1649-1650, 2002

    Abstract To accommodate the small size of the infant urethra, finer, more flexible tubes are often used for urinary catheterization in the pediatric intensive care units. These tubes have the ability to knot in the bladder, occasionally requiring surgical removal. The mechanism of knotting appears to result from excessive intravesical catheter coiling, and as the bladder decompresses the catheter tip can migrate through a coil thereby creating a knot.1,2 Review of the literature from 1975 to 2000 identified 19 cases of urethral catheter knotting in the pediatric bladder with two reports of prostatic urethral involvement. Herein, More >

  • Open Access

    ARTICLE

    Renal cancer and pregnancy in two different female cohorts

    Jack H. Mydlo, Sameer Chawla, Spencer Dom, Michael A. Volpe, Sovrin Shah, Pascal J. Imperato

    Canadian Journal of Urology, Vol.9, No.5, pp. 1634-1636, 2002

    Abstract Purpose: Although human renal cell carcinoma (RCC) is considered refractive to hormone therapy, this lesion can be induced in the Syrian hamster by exogenous estrogen. Human RCC also has been demonstrated to contain estrogen receptors. Since there are significant changes of estrogen levels during pregnancy, we wanted to investigate if there were any associations between the hormonal variations of pregnancy and renal cancer in women using two distinct cohorts.
    Materials and methods: We reviewed the charts of 57 females who presented for treatment of renal cancer. We assessed the size of each tumor radiologically and pathologically, the… More >

  • Open Access

    ARTICLE

    Controversies in the management of localized prostate cancer: consensus development by Canadian urologists

    Laurence H. Klotz1, Yves Fradet2

    Canadian Journal of Urology, Vol.9, Suppl.1, pp. 30-35, 2002

    Abstract This consensus statement emerged from the 2nd Canadian Ura-Oncology Congress, held January 16-20, 2002. The attendees at this meeting comprised approximately 125 urologists from across Canada, representing both community and academic perspectives. The group heard presentations by experts in the field addressing the spectrum of controversies in prostate cancer. After each session, the meeting broke into workshop sessions where attendees discussed the controversies raised by the speakers. Present in each workshop was a reporter who summarized the consensus of the group. These summaries were collected and integrated into a set of questions. At the end of More >

  • Open Access

    ARTICLE

    Prostate cancer: risk categories and role of hormones and radiotherapy

    Himu Lukka

    Canadian Journal of Urology, Vol.9, Suppl.1, pp. 26-29, 2002

    Abstract The Genito-Urinary Radiation Oncologists of Canada (GUROC) have produced a consensus statement on radiotherapy in prostate cancer. This paper summarizes the consensus statement with regard to risk grouping and the role of hormones and radiotherapy. Survival is the most important outcome in the assessment of patients treated with radiotherapy. Other outcomes of interest include disease­free survival, metastatic-free survival, local control, biochemical measures, toxicity, efficacy, and quality of life. Risk groupings based on prognostic data are increasingly used in the management of prostate cancer. These groupings have been correlated to prognosis in several studies, and are… More >

  • Open Access

    ARTICLE

    The role of chemotherapy in advanced prostate cancer

    D. Scott Ernst

    Canadian Journal of Urology, Vol.9, Suppl.1, pp. 21-25, 2002

    Abstract The development of hormone resistance is an unfortunate final common pathway in most patients with advanced prostate cancer, resulting in a narrowing of therapeutic options for the clinician, and limited median survival of 10-12 months for the patient. While cytotoxic chemotherapy has been utilized for many years, its efficacy has been disappointing. Quality of life assessments are increasingly used in assessing response in hormone­resistant prostate cancer (HRPC), and PSA has emerged as an important surrogate marker of response in both local and advanced disease. Estramustine and the taxanes have been investigated, as monotherapy and in More >

  • Open Access

    ARTICLE

    Risk stratification in clinically localized prostate cancer

    Armen G. Aprikian

    Canadian Journal of Urology, Vol.9, Suppl.1, pp. 18-20, 2002

    Abstract Clinical outcomes in patients with localized prostate cancers are heterogeneous. In recent years, analyses of large datasets from multiple centres have yielded a better understanding of how to measure risk in localized prostate cancer. Regardless of whether patients are treated with prostatectomy, radiotherapy, brachytherapy, or expectant management, three factors appear correlated with clinical outcome: biopsy Gleason score, clinical T stage, and serum prostate-specific antigen (PSA). Partin Tables, derived from these parameters and recently updated and refined, may be used to estimate the risk of metastasis and to assess certain aspects of surgical management in clinically… More >

Displaying 23641-23650 on page 2365 of 23797. Per Page